Developing Story: CureWise Goes Live - The AI Platform Built by Cancer Patients, for Cancer Patients

Last time, we had a front row seat to a vision. This time, that vision has a launch date. On June 20th, CureWise officially launched, and for every cancer patient who walks into an oncologist's office with ten minutes and no idea what to ask, it couldn't come at a better time. In this episode of Live From Stage 4, Victoria Goldberg sits down with Steve Brown (founder & CEO of CureWise) and Lisa Booth (metastatic breast cancer advocate and CureWise's patient #2) to talk about what it actually means to have an AI platform that knows your full medical history, speaks your language, and helps you show up to your appointments prepared and empowered. Also joining us: Beta users Lynda Weatherby (MBC patient and Live From Stage 4  team memberr) and her husband Todd Weatherby (CEO of Siemens Advanta, former VP at AWS), bringing the real-world patient and caregiver perspective to the conversation. In this episode: • How CureWise pulls your medical records from multiple institutions automatically • The Cross-Check feature: asking ChatGPT, Claude, and Gemini the same question simultaneously • Why 60% of cancer patients have an actionable mutation, but only 15% are being treated for it • How to prepare for your oncology appointment using AI • The caregiver experience and what's coming next on the roadmap • Pricing, the 7-day free trial, and how to get started Important note: CureWise is not a doctor. It is a powerful tool to help you understand your medical records and have better conversations with your care team. All medical decisions should be made with your physician. 🔗 Sign up at www.curewise.com (http://www.curewise.com/) Thanks for listening. If you enjoyed the episode, subscribe and leave a review — it really helps. Follow us on social media @livefromstage4 and visit our website at www.livefromstage4.org (http://www.livefromstage4.org/) for show notes and links.  Your support helps us continue to share important stories and advocate for those living with metastatic breast cancer. Until next time, take care and keep pushing for progress.